XML 19 R6.htm IDEA: XBRL DOCUMENT v3.21.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Common Stock
Treasury Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated deficit
Accumulated deficit
Cumulative Effect, Period of Adoption, Adjustment
Beginning balance (in shares) at Dec. 31, 2019     51,704 (7,162)        
Beginning balance at Dec. 31, 2019 $ 76,077 $ (768) $ 5 $ (82,087) $ 525,739 $ (33,261) $ (334,319) $ (768)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Stock based compensation 5,316       5,316      
Issuance of restricted stock (in shares)     55          
Issuance of restricted stock 0              
Preferred stock dividends accrued (8,158)       (8,158)      
Amortization of preferred stock issuance costs (750)       (750)      
Shares withheld for taxes in connection with issuance of restricted stock (in shares)     (1)          
Shares withheld for taxes in connection with issuance of restricted stock 0              
Net income (loss) attributable to Synchronoss (3,350)           (3,350)  
Non-controlling interest 0       17   (17)  
Total other comprehensive income (loss) (3,562)         (3,562)    
Ending balance (in shares) at Mar. 31, 2020     51,758 (7,162)        
Ending balance at Mar. 31, 2020 $ 64,805   $ 5 $ (82,087) 522,164 (36,823) (338,454)  
Beginning balance (in shares) at Dec. 31, 2020 51,177   51,177 (7,162)        
Beginning balance at Dec. 31, 2020 $ 43,282   $ 5 $ (82,087) 499,348 (28,213) (345,771)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Stock based compensation 2,813       2,813      
Issuance of restricted stock (in shares)     154          
Issuance of restricted stock 0              
Preferred stock dividends accrued (9,407)       (9,407)      
Amortization of preferred stock issuance costs (1,123)       (1,123)      
Net income (loss) attributable to Synchronoss (12,366)           (12,366)  
Non-controlling interest 0       (336)   336  
Total other comprehensive income (loss) $ (1,136)         (1,136)    
Ending balance (in shares) at Mar. 31, 2021 51,331   51,331 (7,162)        
Ending balance at Mar. 31, 2021 $ 22,063   $ 5 $ (82,087) $ 491,295 $ (29,349) $ (357,801)